
Xbrane Biopharma
0.162
SEK
-4.82 %
XBRANE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
-4.82%
+3.18%
+0.75%
-19.2%
-3.46%
+5.07%
-98.63%
-96.87%
-95.75%
Xbrane Biopharma is a biotechnology company. The company specializes in research and development of drugs for the treatment of critical illnesses. Today, the business is focused on research in microspherical technology and in the development of protein molecules. The products are used in the treatment of prostate cancer and endometriosis, as well as in rare and serious eye diseases. The company's head office is located in Solna.
Read moreMarket cap
248.21M SEK
Turnover
917.25K SEK
Revenue
238.73M
EBIT %
-134.95 %
P/E
-
Dividend yield-%
-
Financial calendar
21/2
2025
Annual report '24
5/5
2025
General meeting '25
8/5
2025
Interim report Q1'25
ShowingAll content types

Antalet aktier och röster i Xbrane har förändrats till följd av att 2 706 898 aktier har emitterats under januari månad genom utnyttjande av teckningsoptioner i december 2025.
The number of shares and votes in Xbrane has changed as a result of 2,706,898 shares being issued during January through the exercise of warrants in December 2024.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools